文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Methylation profiling of CpG islands in human breast cancer cells
侵权投诉

Methylation profiling of CpG islands in human breast cancer cells

© 1999 Oxford University PressHuman Molecular Genetics, 1999, Vol. 8, No. 3459–470

Methylation profiling of CpG islands in human breastcancer cells

Tim Hui-Ming Huang*, Martin R. Perry and Douglas E. Laux

Departments of Pathology and Anatomical Sciences, Ellis Fischel Cancer Center, University of Missouri, 115 Business Loop I-70 West, Columbia, MO 65203, USA

Received October 2, 1998; Revised and Accepted December 9, 1998

CpG island hypermethylation is known to be asso-ciated with gene silencing in cancer. This epigeneticevent is generally accepted as a stochastic process intumor cells resulting from aberrant DNA methyltrans-ferase (DNA-MTase) activities. Specific patterns ofCpG island methylation could result from clonal selec-tion of cells having growth advantages due to silen-cing of associated tumor suppressor genes. Alterna-tively, methylation patterns may be determined byother, as yet unidentified factors. To explore further theunderlying mechanisms, we developed a novel array-based method, called differential methylation hybrid-ization (DMH), which allows a genome-wide screeningof hypermethylated CpG islands in tumor cells. DMHwas used to determine the methylation status of >276CpG island loci in a group of breast cancer cell lines.Between 5 and 14% of these loci were hypermethylatedextensively in these cells relative to a normal control.Pattern analysis of 30 positive loci by Southern hybrid-ization indicated that CpG islands might differ in theirsusceptibility to hypermethylation. Loci exhibiting pre-existing methylation in normal controls were moresusceptible to de novo methylation in these cancercells than loci without this condition. In addition, thesecell lines exhibited different intrinsic abilities to methy-late CpG islands not directly associated with methyl-transferase activities. Our study provides evidencethat, aside from random DNA-MTase action, additionalcellular factors exist that govern aberrant methylationin breast cancer cells.INTRODUCTION

In mammals, DNA methylation usually occurs at cytosines located5′ of guanines, known as CpG dinucleotides. DNA(cytosine-5)-methyltransferase (DNA-MTase) catalyzes this reaction by addinga methyl group from S-adenosyl-L-methionine to the fifth carbonposition of the cytosines (1). The DNMT1 gene has been shownpreviously to be responsible for the DNA-MTase activity in humans(2). More recently, other genes encoding methylating enzymes havebeen implicated in mice and humans (3–5). While DNA-MTasefavors hemimethylated substrates for its normal maintenanceactivity in the cell, the enzyme also exhibits an ability to methylateCpG sites de novo (6). Most cytosines within CpG dinucleotides aremethylated in the human genome, but some remain unmethylated inspecific GC-rich areas, called CpG islands (7). These 1–2 kb longDNA sequences are located in the promoter and first exon regionsof ~60% of all genes (8).

DNA methylation is known to play a role in regulating geneexpression during cell development. This epigenetic event frequent-ly is associated with transcriptional silencing of imprinted genes,some repetitive elements and genes on the inactive X chromosome(9,10). In neoplastic cells, it has been observed that the normallyunmethylated CpG islands can become aberrantly methylated, orhypermethylated (11,12). If hypermethylation occurs in CpGislands of genes related to growth-inhibitory activities, it may leadto associated transcriptional silencing and promote neoplastic cellproliferation. In addition to classic genetic mutations, CpG islandhypermethylation is an alternative mechanism for inactivation oftumor suppressor genes (12).

The molecular mechanisms underlying CpG island hyper-methylation in cancer recently have been explored. A substantialbody of evidence indicates that increased DNA-MTase levels cancontribute to tumorigenesis by promoting de novo methylation ofCpG island sequences (13,14). Recent data have shown thatdysregulation of a cell cycle regulator, p21, that normally modulatesDNA-MTase action, may also promote de novo methylation (15).Studies have suggested that local cis-acting signals and trans-actingfactors capable of preventing specific CpG islands from de novomethylation can be disrupted in tumor cells (16–18). Presently, thereis no direct evidence that disturbances of such local factors mightimpose de novo methylation of specific CpG islands. Rather, denovo methylation is commonly thought to be a generalizedphenomenon associated with a stochastic process in tumor cellspossessing aberrant DNA-MTase activities (11,19). This randommethylation process can occur at CpG sites located within theregulatory regions of tumor suppressor genes. The progressivesilencing of their transcripts may provide tumor cells with a growthadvantage, and the specific hypermethylated sites observed inparticular cancer types could be the end results of clonal selectionduring tumor development.

Traditionally, methylation analysis has been carried out bySouthern hybridization, which assesses a few methylation-sensitive restriction sites within CpG islands of known genes.

Downloaded from hmg.oxfordjournals.org at Wuhan University on January 19, 2011

*To whom correspondence should be addressed. Tel: +1 573 882 1276; Fax: +1 573 884 5206; Email: huangh@health.missouri.edu

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email